Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126289211 | 12628921 | 1 | I | 20160728 | 20160808 | 20160808 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-062741 | BRISTOL MYERS SQUIBB | 8.00 | DEC | F | Y | 0.00000 | 20160808 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126289211 | 12628921 | 1 | PS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 500 MG, UNK | U | 125118 | 500 | MG | SOLUTION FOR INFUSION | ||||||
| 126289211 | 12628921 | 2 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, UNK | U | 125118 | 750 | MG | SOLUTION FOR INFUSION | ||||||
| 126289211 | 12628921 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 20 MG, QWK | U | 0 | 20 | MG | /wk | ||||||
| 126289211 | 12628921 | 4 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 126289211 | 12628921 | 5 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126289211 | 12628921 | 6 | C | LASIX | FUROSEMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126289211 | 12628921 | 7 | C | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126289211 | 12628921 | 8 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126289211 | 12628921 | 1 | Rheumatoid arthritis |
| 126289211 | 12628921 | 3 | Product used for unknown indication |
| 126289211 | 12628921 | 4 | Product used for unknown indication |
| 126289211 | 12628921 | 5 | Product used for unknown indication |
| 126289211 | 12628921 | 6 | Product used for unknown indication |
| 126289211 | 12628921 | 7 | Product used for unknown indication |
| 126289211 | 12628921 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126289211 | 12628921 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126289211 | 12628921 | Malaise | |
| 126289211 | 12628921 | Neoplasm | |
| 126289211 | 12628921 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |